Literature DB >> 23640383

Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment.

Shichong Yu1, Nan Wang, Xiaoyun Chai, Baogang Wang, Hong Cui, Qingjie Zhao, Yan Zou, Qingyan Sun, Qingguo Meng, Qiuye Wu.   

Abstract

A series of fluconazole analogues containing 1,2,3-triazole fragment have been designed and synthesized on the basis of the active site of the cytochrome P450 14α-demethylase (CYP51). Their structures were characterized by (1)H NMR, (13)C NMR and LC-MS. The MIC80 values indicate that the target compounds 1a-r showed higher activities against nearly all the fungi tested to some extent except against Aspergillus fumigatus. Compounds 1c, e, f, l and p showed 128 times higher activity (with the MIC80 value of 0.0039 mg/mL) than that of fluconazole against Candida albicans and also showed higher activity than that of the other positive controls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640383     DOI: 10.1007/s12272-013-0063-0

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues.

Authors:  Shashwat Malhotra; Seema Singh; Neha Rana; Shilpi Tomar; Priyanka Bhatnagar; Mohit Gupta; Suraj K Singh; Brajendra K Singh; Anil K Chhillar; Ashok K Prasad; Christophe Len; Pradeep Kumar; Kailash C Gupta; Anjani J Varma; Ramesh C Kuhad; Gainda L Sharma; Virinder S Parmar; Nigel G J Richards
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

2.  N-Phenacyldibromobenzimidazoles-Synthesis Optimization and Evaluation of Their Cytotoxic Activity.

Authors:  Anna Kowalkowska; Konrad Chojnacki; Maciej Multan; Jan K Maurin; Edyta Łukowska-Chojnacka; Patrycja Wińska
Journal:  Molecules       Date:  2022-07-07       Impact factor: 4.927

3.  Theoretical calculations of molecular descriptors for anticancer activities of 1, 2, 3-triazole-pyrimidine derivatives against gastric cancer cell line (MGC-803): DFT, QSAR and docking approaches.

Authors:  Rhoda Oyeladun Oyewole; Abel Kolawole Oyebamiji; Banjo Semire
Journal:  Heliyon       Date:  2020-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.